JB Chemicals has received approval from the US FDA for Bisoprolol tablets in strengths of 5 mg and 10 mg, (Photo Source: Company website).
JB Chemicals and Pharmaceuticals Ltd. on Friday said it has received approval from the US health regulator to market a generic medication to treat high blood pressure.
The company has received approval from the US Food and Drug Administration for Bisoprolol tablets in strengths of 5 mg and 10 mg, the company said in a regulatory filing.
The company's product is the generic version of Teva's Zebeta tablets, which are indicated for the management of hypertension.
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.
